Therapy News and Research

RSS

Lactate component responsible for anti-tumor effects of plasma medicine, research shows

Physical plasma is one of the four fundamental states of matter, together with solid, liquid, and gas, and can be completely or partially ionized (thermal/hot or non-thermal/cold plasma, respectively).

15 Dec 2016

Anti-platelet drug may slow spread of colon and pancreatic cancer cells

Researchers from Oregon Health and Science University have found that aspirin may slow the spread of some types of colon and pancreatic cancer cells. The paper is published in the American Journal of Physiology—Cell Physiology.

15 Dec 2016

Initial rheumatoid arthritis symptoms often invisible to others, survey reveals

Rheumatoid Arthritis is a chronic disease characterized by joint swelling, pain, and stiffness that affects approximately 1.3 million individuals in the U.S. Unlike the more common osteoarthritis, RA is an autoimmune condition in which the body's immune system mistakenly attacks healthy tissue.

15 Dec 2016

Telemedicine eye screening programs could help bridge gap in caring for premature babies

Retinopathy of prematurity (ROP) occurs when abnormal blood vessels grow over the retina and may lead to blindness in premature babies.

15 Dec 2016

Scientists explain concept of combining NO gas therapy with starvation of tumor cells for nanomedical treatment

Biocompatible nanocapsules, loaded with an amino acid and equipped with an enzyme now combine two anti-tumor strategies into a synergistic treatment concept. Researchers hope this increases effectiveness and decreases side effects.

14 Dec 2016

Phenotypic Personalized Medicine could surmount treatment challenges for acute lymphoblastic leukemia

A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has the potential to help doctors personalize drug doses.

14 Dec 2016

Novel plasma medicine with anti-tumor effect discovered

Nagoya University researchers develop cold plasma-activated Ringer's solution for chemotherapy. The solution has anti-tumor effects in vitro and in vivo that derive from the lactate component.

14 Dec 2016

UNIST study could open up new avenues of research in cancer treatment

The new study, by researchers from UNIST demonstrates a more holistic light-based treatment to nuke cancer cells instead of surgery. The results, reported in the September issue of the Journal of the American Chemical Society, could open up new avenues of research in cancer treatment.

14 Dec 2016

One fifth of breast cancer patients do not complete their prescribed endocrine therapy

Around 20% of breast cancer patients do not complete prescribed endocrine therapy, researchers report at the ESMO Asia 2016 Congress in Singapore.1 The study in over 5,500 women found that younger patients and those who had taken hormone replacement therapy (HRT) were less likely to adhere to their medicine.

14 Dec 2016

Innovation in stroke aftercare across Europe: an interview with Professor Urs Fischer

Stroke is the epidemic disease of the twenty-first century and the second most frequent cause of death in 2011, accounting for 11% of all deaths worldwide. Stroke is also the second most important cause of permanent disability and...

13 Dec 2016

IPF diagnosis: how do patients feel about the discussion with their physician?

IPF (Idiopathic Pulmonary Fibrosis) is a difficult disease to diagnose. Many patients will experience many visits to the doctor and some may even be told they have a different respiratory condition before they finally get the correct diagnosis that...

12 Dec 2016

UNMC seeking patients with lymphoma to evaluate two-drug oral therapy

The University of Nebraska Medical Center is seeking 24 patients to enroll in a Phase 2a study to evaluate the safety and efficacy of two oral cancer drugs for patients with diffuse large B-cell lymphoma who have relapsed or are resistant to other traditional therapies.

9 Dec 2016

Symptoms from other causes may be mistaken for side effects of breast cancer drug

Women taking tamoxifen to prevent breast cancer were less likely to continue taking the drug if they suffered nausea and vomiting, according to new data presented at the San Antonio Breast Cancer Symposium today (Friday).

9 Dec 2016

Depression drug can alleviate joint pain in postmenopausal women treated for breast cancer

A drug typically used to treat depression and anxiety can significantly reduce joint pain in postmenopausal women being treated for early stage breast cancer, according to new SWOG research to be presented Friday at a special plenary presentation at the San Antonio Breast Cancer Symposium.

9 Dec 2016

Controversial hormone could fight against recurring breast cancers

An international team of researchers involving the University of Adelaide is tackling the controversy over what some scientists consider to be a "harmful" hormone, arguing that it could be a game changer in the fight against recurring breast cancers that are resistant to standard treatments.

9 Dec 2016

Image-guided percutaneous needle biopsies after NST identify breast cancer patients who achieve pCR

In a pilot study conducted at The University of Texas MD Anderson Cancer Center, image-guided biopsies identified select breast cancer patients who achieved pathologic complete response (pCR) after chemotherapy and/or targeted therapy, neoadjuvant systemic therapy (NST).

9 Dec 2016

Psychiatrist explains how the brain blocks memory to help get through traumatic event

Everyone has done something they probably want to forget—falling face first on the stage at your high school graduation or asking a woman how far along she is only to find out she isn't even pregnant.

9 Dec 2016

Jets of plasma used in arc welding may help kill cancer cells and heal wounds

JETS of plasma traditionally used in arc welding could soon be used to kill cancer cells and heal wounds.

9 Dec 2016

Defective ribosomes linked to aggressive form of multiple myeloma

20 to 40 percent of the patients with multiple myeloma - a type of leukaemia - have a defect in the ribosome, the protein factory of the cell.

9 Dec 2016

Proton Partners acquires Blue Phantom2 data acquisition system to support innovative cancer treatment

The first ever Proton Partners International site, specialising in proton beam therapy, has acquired a Blue Phantom2 data acquisition system from IBA to commission its IBA Proteus ONE compact proton therapy machine and Elekta Versa HD linear accelerator.

9 Dec 2016

Therapy News and Research

Lactate component responsible for anti-tumor effects of plasma medicine, research shows

Anti-platelet drug may slow spread of colon and pancreatic cancer cells

Initial rheumatoid arthritis symptoms often invisible to others, survey reveals

Telemedicine eye screening programs could help bridge gap in caring for premature babies

Scientists explain concept of combining NO gas therapy with starvation of tumor cells for nanomedical treatment

Phenotypic Personalized Medicine could surmount treatment challenges for acute lymphoblastic leukemia

Novel plasma medicine with anti-tumor effect discovered

UNIST study could open up new avenues of research in cancer treatment

One fifth of breast cancer patients do not complete their prescribed endocrine therapy

Innovation in stroke aftercare across Europe: an interview with Professor Urs Fischer

IPF diagnosis: how do patients feel about the discussion with their physician?

UNMC seeking patients with lymphoma to evaluate two-drug oral therapy

Symptoms from other causes may be mistaken for side effects of breast cancer drug

Depression drug can alleviate joint pain in postmenopausal women treated for breast cancer

Controversial hormone could fight against recurring breast cancers

Image-guided percutaneous needle biopsies after NST identify breast cancer patients who achieve pCR

Psychiatrist explains how the brain blocks memory to help get through traumatic event

Jets of plasma used in arc welding may help kill cancer cells and heal wounds

Defective ribosomes linked to aggressive form of multiple myeloma

Proton Partners acquires Blue Phantom2 data acquisition system to support innovative cancer treatment

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News